F-group (family)
3156.1.1.1 COX2
Ligands and drugs
724
Member domains
370
with ligand contacts (≤ 4 Å)
51.1% of members
287
with DrugDomain annotations
39.6% of members
26
with a DrugBank compound
3.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3156.1.1.1 belongs to X-group 3156 Cupredoxin-like, which binds 7.4 ligand superclasses per 20 proteins, narrower than 55% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02676 | B3P | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | 6 |
| DB03151 | CUZ | mu4-sulfido-quadro-tetracopper | 5 |
| DB03317 | HEC | Ferroheme C | 5 |
| DB04079 | HTO | Heptane-1,2,3-Triol | 3 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 2 |
| DB03796 | PLM | Palmitic Acid | 2 |
| DB00120 | PHE | Phenylalanine | 1 |
| DB02451 | BNG | B-nonylglucoside | 1 |
| DB04464 | — | N-Formylmethionine | 1 |
| DB05412 | — | Talmapimod | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CUA | DINUCLEAR COPPER ION | 269 |
| MGmetal | MAGNESIUM ION | 255 |
| CUmetal | COPPER (II) ION | 84 |
| HEC | HEME C | 23 |
| CDmetal | CADMIUM ION | 20 |
| MNmetal | MANGANESE (II) ION | 18 |
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | 15 |
| CU1metal | COPPER (I) ION | 13 |
| PGV | (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE | 9 |
| 9Y0 | (2R)-3-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-2-(palmitoyloxy)propyl (E)-octadec-9-enoate | 8 |
| WUO | acyl-phosphatidyl-myo-inositol dimannoside (AcPIM2) | 8 |
| B3P | 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL | 6 |
| HTH | (2S,3R)-heptane-1,2,3-triol | 6 |
| DMU | DECYL-BETA-D-MALTOPYRANOSIDE | 5 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 5 |
| IX7 | [(2~{R})-3-[[(1~{S},2~{R},3~{R},4~{S},5~{S},6~{R})-2-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-(hexadecanoyloxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-6-[(2~{R},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-3,4,5-tris(oxidanyl)cyclohexyl]oxy-oxidanyl-phosphoryl]oxy-2-undecanoyloxy-propyl] (10~{S})-10-methylhenicosanoate | 4 |
| TRD | TRIDECANE | 4 |
| HTO | HEPTANE-1,2,3-TRIOL | 3 |
| ZNmetal | ZINC ION | 2 |
| BNG | nonyl beta-D-glucopyranoside | 1 |